In a second PD study in tumor-free mice, a dose-dependent increase of proliferation marker Ki-67 expression in NK and CD8+ T cells translated into a relative expansion of both subsets in blood after single dose treatment of 0.1–2.5 mg/kg GT-00AxIL15 (Figure 4D,E). The gene discussed is CD8A; the disease is neoplasm.